The Lancet HIV in conversation with
από The Lancet Group
Implementation of long-acting injectable cabotegravir for PrEP in…
Σχετικά με αυτό το podcast
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Επεισόδια
Τα νεότερα 20 από 71 επεισόδια
- Implementation of long-acting injectable cabotegravir for PrEP in Brazil with Beatriz Grinsztejn · 25 λεπ. · Επεισόδιο 8Daily oral PrEP is highly effective, but taking a pill consistently can be challenging. Could long-acting injectable cabotegravir help close gaps in HIV prevention? What would it…
- Joanne Langley and Innocent Valea on Ebola vaccine in people living with HIV · 25 λεπ. · Επεισόδιο 7Ebola outbreaks occur in areas where many people are living with HIV; however, there is very little evidence on how people with HIV respond to Ebola vaccines. In this edition of…
- Janet Turan and Zachary Kwena on home-based couples testing and counselling for HIV · 23 λεπ. · Επεισόδιο 6HIV remains underdiagnosed among men in many settings, contributing to ongoing transmission. When women seek care during pregnancy, there is an opportunity to reach out to their…
- Amy Justice and Keri Althoff on the Lancet HIV Commission on ageing and HIV · 23 λεπ. · Επεισόδιο 5Living longer with HIV is one of medicine's greatest success stories, but longevity brings new challenges. By 2040, more than half of all people living with HIV are expected to…
- Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy · 19 λεπ. · Επεισόδιο 4Some people on HIV treatment have a viral load that won't fully suppress. In this episode, we speak with Annemarie Wensing (University Medical Center Utrecht in The Netherlands…
- David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV · 30 λεπ. · Επεισόδιο 3Transgender women and transfeminine people living with HIV face layers of stigma and multiple challengers that contribute to high levels of mental ill health and substance…
- Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial · 26 λεπ. · Επεισόδιο 2Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs…
- Colette Smith on the Positive Voices UK survey recording health needs of people living with HIV · 14 λεπ.People living with HIV often have many health needs beyond their antiretroviral medication. Editor in Chief Peter Hayward talks to Colette Smith of the Institute for Global…
- Eran Shorer on Parkinsonism in people with virally suppressed HIV · 19 λεπ.Ageing with HIV brings new challenges. Even with effective ART, people ageing with HIV face increased risk of parkinsonism. Eran F Shorer from the Icahn School of Medicine at…
- Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa · 43 λεπ.Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six…
- Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV · 21 λεπ.Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to…
- Deborah Persaud on the possibility of HIV remission in neonates · 36 λεπ.In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed…
- Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis · 17 λεπ.Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of…
- Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV · 19 λεπ.Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle…
- Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda · 25 λεπ.Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr…
- Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV · 16 λεπ.In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a…
- Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV · 14 λεπ.Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality…
- Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality · 24 λεπ.Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten…
- Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes · 21 λεπ.Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US…
- Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women · 23 λεπ.Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure…








